Navigation Links
Syngenta Enters Into Research Collaboration With Anhui Academy, China

BASEL, Switzerland, Feb. 10 /PRNewswire/ -- Syngenta today announced that it has agreed an eight-year research collaboration with Anhui Rice Research Institute (ARRI) of Anhui Academy of Agricultural Sciences in China. The collaboration program is centered around conducting laboratory and field tests of novel gene functions and will focus on drought tolerance and nitrogen utilization optimization in key crops such as corn and soybean. ARRI will work closely with Syngenta's new biotech research and technology center in Beijing which was opened in October last year.

"This collaboration will accelerate our research and increase our efficiency and competitiveness," says Xun Wang, Head of Syngenta Biotechnology China. "ARRI has strong expertise and experience in genetics, breeding and field experiments."

The base crop for the program will be rice, which is highly suited for gene research. It is a well characterized crop regarding genetic, molecular and agronomic information and its genome is closely related to those of major crops such as corn. The relatively short growing cycle of rice will also allow more testing to be completed in a shorter time frame.

"We are very excited and honored to be entering into collaboration with Syngenta, a world class agribusiness with global expertise. I strongly believe scientists from both sides will work closely together to develop cutting-edge technologies and provide novel solutions to agriculture," says Jianbo Yang, President of Anhui Academy of Agricultural Sciences.

The research agreement is part of Syngenta's efforts to work closely with Chinese academics. In 2007, Syngenta entered into a five-year research collaboration with the Institute of Genetics and Developmental Biology (IGDB) in Beijing on the development of novel agronomic traits for key crops such as corn, soybean, wheat, sugar beet and sugar cane.

Founded in 1987, ARRI is a leading institute in rice research and technology innovation in Anhui Province in China. Since its establishment, ARRI has undertaken many key projects such as with the United Nations Development Programme and the Chinese National Natural Science Foundation.

Syngenta is one of the world's leading companies with more than 24,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to

Cautionary Statement Regarding Forward-Looking Statements

This document contains forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor.

    Media contacts:

    Medard Schoenmaeckers
    Switzerland +41 61 323 2323

    Anne Burt
    USA +1 202 628 2372

    Analyst/Investor contacts:

    Jennifer Gough
    Switzerland +41 61 323 5059
    USA +1 202 737 6521

    John Hudson
    Switzerland +41 61 323 6793
    USA +1 202 737 6520

SOURCE Syngenta
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Syngenta and Metabolon Inc. in Collaborative Research Agreement for Biochemical Profiling Technology
2. USDA Approves Syngenta and John Deere for Broadened Biotechnology Endorsement for Corn Crop Insurance
3. Syngenta To Build Major Global Biotech Research Center in Beijing, China
4. Syngenta and The Royal Society of Chemistry Launch African Science Initiative
5. Syngenta Licenses Chromatin Gene Stacking Technology
6. Sinovac Enters Veterinary Vaccine Market with Inactivated Rabies Vaccine
7. China Biologic Products Enters into Short-Term Loan Agreement
8. Micromet Enters Into Agreement for Solid Tumor BiTE Antibody with Bayer Schering Pharma AG
9. Mach One Corporation Enters Letter of Intent
10. Perceptive Informatics Enters License Agreement With EuroQoL Group to Provide Enhanced Standardization for ePRO Solution
11. Peregrine Pharmaceuticals Enters Into a Loan Agreement for up to $10 Million
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... , President and CEO of Neurocrine Biosciences, will be ... in New York . ... the website approximately 5 minutes prior to the presentation ... of the presentation will be available on the website ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... company uBiome, were featured on AngelList early in their initial angel funding process. ... AngelList syndicate for individuals looking to make early stage investments in the microbiome ...
(Date:11/24/2015)... /CNW/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ... the quarter ended September 30, 2015. Amounts, unless ... presented under International Financial Reporting Standards ("IFRS"). ... Andrew Rae , President & CEO of ... only value enriching for this clinical program, but ...
(Date:11/24/2015)... , November 24, 2015 ... market research report "Oligonucleotide Synthesis Market by Product & ... Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & ... by MarketsandMarkets, the market is expected to reach USD ... 2015, at a CAGR of 10.1% during the forecast ...
Breaking Biology Technology:
(Date:11/12/2015)... , Nov. 12, 2015  A golden retriever ... Duchenne muscular dystrophy (DMD) has provided a new lead ... Children,s Hospital, the Broad Institute of MIT and Harvard ... Brazil . Cell, pinpoints ... dogs "escape" the disease,s effects. The Boston Children,s lab ...
(Date:11/12/2015)... , Nov. 11, 2015   Growing ... reliable analytical tools has been paving the way ... qualitative determination of discrete analytes in clinical, agricultural, ... are being predominantly used in medical applications, however, ... environmental sectors due to continuous emphasis on improving ...
(Date:11/10/2015)... Nov. 10, 2015  In this report, ... basis of product, type, application, disease indication, ... this report are consumables, services, software. The ... safety biomarkers, efficacy biomarkers, and validation biomarkers. ... are diagnostics development, drug discovery and development, ...
Breaking Biology News(10 mins):